We analyzed 173 HCC patients and demonstrated that elevated PMS2 expression was significantly associated with poorer disease-free survival (DFS) (<i>p</i> < 0.001) and overall survival (OS) (<i>p</i> < 0.001). Here, PMS2 is linked to hepatocellular carcinoma.